Kunwei Shen

10.1k total citations · 1 hit paper
231 papers, 5.2k citations indexed

About

Kunwei Shen is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kunwei Shen has authored 231 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Oncology, 141 papers in Cancer Research and 58 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kunwei Shen's work include Breast Cancer Treatment Studies (111 papers), HER2/EGFR in Cancer Research (78 papers) and Breast Lesions and Carcinomas (48 papers). Kunwei Shen is often cited by papers focused on Breast Cancer Treatment Studies (111 papers), HER2/EGFR in Cancer Research (78 papers) and Breast Lesions and Carcinomas (48 papers). Kunwei Shen collaborates with scholars based in China, United States and Taiwan. Kunwei Shen's co-authors include Xiaosong Chen, Yan Mao, Jiayi Wu, Ou Huang, David Garfield, Xiaochun Fei, Evan T. Keller, Jianhua Wang, Weiguo Chen and Shuning Ding and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Kunwei Shen

213 papers receiving 5.1k citations

Hit Papers

Stromal cells in tumor microenvironment and breast cancer 2012 2026 2016 2021 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Stromal cells in tumor microenvironment and breast cancer
    2012 549 citations Yan Mao, David Garfield et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kunwei Shen China 37 2.7k 2.2k 1.6k 914 797 231 5.2k
Beth Overmoyer United States 33 4.4k 1.6× 1.9k 0.9× 1.5k 0.9× 1.3k 1.4× 577 0.7× 143 6.2k
Daniele Generali Italy 42 3.1k 1.1× 2.1k 1.0× 2.5k 1.5× 1.7k 1.9× 499 0.6× 232 6.2k
Dongxia Gao Canada 27 2.9k 1.1× 2.4k 1.1× 1.5k 1.0× 761 0.8× 757 0.9× 57 5.1k
Aurelia Noske Germany 38 3.2k 1.2× 1.9k 0.9× 3.2k 2.0× 705 0.8× 749 0.9× 102 6.8k
Ja Seung Koo South Korea 43 2.4k 0.9× 2.8k 1.3× 2.7k 1.6× 807 0.9× 896 1.1× 231 6.3k
Laurent Arnould France 38 2.8k 1.0× 1.4k 0.6× 1.4k 0.9× 651 0.7× 670 0.8× 172 5.3k
Otto Metzger United States 30 3.2k 1.2× 1.7k 0.8× 1.4k 0.8× 1.4k 1.5× 529 0.7× 117 4.8k
Dilip D. Giri United States 37 2.9k 1.1× 2.4k 1.1× 3.0k 1.8× 712 0.8× 1.1k 1.4× 94 7.0k
Thomas Hatschek Sweden 29 2.4k 0.9× 1.9k 0.9× 1.1k 0.7× 956 1.0× 480 0.6× 100 4.5k
Hervé Bonnefoi France 31 2.8k 1.0× 2.5k 1.2× 1.6k 1.0× 994 1.1× 758 1.0× 135 5.0k

Countries citing papers authored by Kunwei Shen

Since Specialization
Citations

This map shows the geographic impact of Kunwei Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunwei Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunwei Shen more than expected).

Fields of papers citing papers by Kunwei Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunwei Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunwei Shen. The network helps show where Kunwei Shen may publish in the future.

Co-authorship network of co-authors of Kunwei Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Kunwei Shen. A scholar is included among the top collaborators of Kunwei Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunwei Shen. Kunwei Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zheng, Anqi Li, Yujie Lu, et al.. (2024). Association of tumor immune infiltration and prognosis with homologous recombination repair genes mutations in early triple-negative breast cancer. Frontiers in Immunology. 15. 1407837–1407837. 2 indexed citations
2.
Wang, Han, Ruo Wang, Hong Jin, et al.. (2023). An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancer. Frontiers in Immunology. 14. 1295558–1295558. 10 indexed citations
3.
Ding, Shuning, Q. L. Niu, Qingchen Zhu, et al.. (2023). Single‐cell atlas reveals a distinct immune profile fostered by T cell‐B cell crosstalk in triple negative breast cancer. Cancer Communications. 43(6). 661–684. 29 indexed citations
4.
Li, Shuai Cheng, et al.. (2023). Time interval between breast cancer diagnosis and surgery is associated with disease outcome. Scientific Reports. 13(1). 12091–12091. 7 indexed citations
5.
Chen, Chuying, Wei‐Xiang Qi, Gang Cai, et al.. (2023). The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients. The Breast. 68. 142–148. 9 indexed citations
6.
Dong, Shuwen, Jing Yu, Xiaosong Chen, & Kunwei Shen. (2023). Association of serum lipid levels and clinical outcomes in early breast cancer patients. Therapeutic Advances in Medical Oncology. 15. 2621740–2621740. 6 indexed citations
7.
Cai, Gang, Cheng Xu, Rong Cai, et al.. (2022). Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy. Journal of Oncology. 2022. 1–10.
8.
Mo, Jialin, Fang Liu, Xi Sun, et al.. (2021). Inhibition of the FACT Complex Targets Aberrant Hedgehog Signaling and Overcomes Resistance to Smoothened Antagonists. Cancer Research. 81(11). 3105–3120. 12 indexed citations
9.
Yu, Jing, Jiayi Wu, Ou Huang, Xiaosong Chen, & Kunwei Shen. (2021). A Smartphone-Based App to Improve Adjuvant Treatment Adherence to Multidisciplinary Decisions in Patients With Early-Stage Breast Cancer: Observational Study. Journal of Medical Internet Research. 23(9). e27576–e27576. 18 indexed citations
10.
Li, Shuai, Jiayi Wu, Ou Huang, et al.. (2021). Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patients. BMC Cancer. 21(1). 807–807. 1 indexed citations
11.
Zhu, Yifei, Tiange Wang, Yiwei Tong, Xiaosong Chen, & Kunwei Shen. (2021). 21-Gene Recurrence Assay Associated With Favorable Metabolic Profiles in HR-Positive, HER2-Negative Early-Stage Breast Cancer Patients. Frontiers in Endocrinology. 12. 725161–725161. 2 indexed citations
12.
Ding, Shuning, Xiaosong Chen, & Kunwei Shen. (2020). Single‐cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy. Cancer Communications. 40(8). 329–344. 166 indexed citations
13.
14.
15.
Zhang, Yuzi, Qing Qu, Yan Mao, & Kunwei Shen. (2015). [Effect of body mass index on disease-free and overall survival in Chinese women with breast cancer].. PubMed. 37(5). 395–9. 2 indexed citations
16.
Huang, Jiahui, Xiaosong Chen, Xiaochun Fei, et al.. (2015). [Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node].. PubMed. 53(12). 941–6. 6 indexed citations
17.
Chen, Xiaosong, Xiaochun Fei, David Garfield, et al.. (2015). Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients. BMC Cancer. 15(1). 822–822. 26 indexed citations
18.
Chen, Xiaosong, Mingang Hao, Xueqing Sun, et al.. (2013). Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer. Molecular Cancer Research. 11(10). 1269–1278. 36 indexed citations
19.
Shen, Kunwei, et al.. (2013). The accuracy of preoperatively predicting axillary lymph node status in breast cancer patients by ultrasonography and MRI. Zhonghua putong waike zazhi. 28(4). 259–262. 2 indexed citations
20.
Shen, Kunwei. (2006). Significantly Higher Pathologic Complete Remission Rate after Neoadjuvant Therapy with Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy. Journal of Evidence-Based Medicine. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beth Overmoyer Breakdown of academic impact, for papers by Daniele Generali Breakdown of academic impact, for papers by Dongxia Gao Breakdown of academic impact, for papers by Aurelia Noske Breakdown of academic impact, for papers by Ja Seung Koo Breakdown of academic impact, for papers by Laurent Arnould Breakdown of academic impact, for papers by Otto Metzger Breakdown of academic impact, for papers by Dilip D. Giri Breakdown of academic impact, for papers by Thomas Hatschek Breakdown of academic impact, for papers by Hervé Bonnefoi
Rankless by CCL
2026